XG
XGEN.XETRA Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc
- EUR
No recent price
- Total assets
- 3.37M
- Expense ratio
- 0.30%
- Dividend yield
- -
- 1-year return
- +32.52%
- Holdings
- 10
- Since
- 2022
Fund data as reported by the issuer, updated Nov 3, 2026. Total assets are in the fund's base currency.
What does XGEN.XETRA invest in?
Tracks Morningstar Gbl Health NR USD- Mostly US stocks (78.2%)
- Largest sector: Healthcare (96.7%)
- Largest region: North America (79.3%)
- Top 3 holdings: 16.4% of the fund
Asset allocation
- US stocks 78.2%
- Non-US stocks 23.2%
- Cash 0.1%
- Bonds 0.0%
Top holdings
- Illumina Inc 5.80%
- Natera Inc 5.76%
- Danaher Corporation 4.82%
- Moderna Inc 4.73%
- Agilent Technologies Inc 4.65%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc performance
Sharpe ratio 0.91- This year
- +29.13%
- 1 year
- +32.52%
- 3 years
- +21.37%
- 5 years
- 0.00%
Volatility 21.0% over 1 year and 18.3% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
XGEN.XETRA price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc top holdings
45.9% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Illumina Inc ILMN.US | Healthcare | United States | 5.80% |
| Natera Inc NTRA.US | Healthcare | United States | 5.76% |
| Danaher Corporation DHR.US | Healthcare | United States | 4.82% |
| Moderna Inc MRNA.US | Healthcare | United States | 4.73% |
| Agilent Technologies Inc A.US | Healthcare | United States | 4.65% |
| Lonza Group AG LONN.SW | Healthcare | Switzerland | 4.37% |
| GSK plc GSK.US | Healthcare | United States | 4.20% |
| Vertex Pharmaceuticals Inc VRTX.US | Healthcare | United States | 4.15% |
| Guardant Health Inc GH.US | Healthcare | United States | 3.75% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 3.73% |
XGEN.XETRA sector exposure
- Healthcare96.7%
- Financial Services0.1%
Share of the stocks in the fund.
XGEN.XETRA regional exposure
- North America79.3%
- Europe Developed11.7%
- Asia Emerging6.5%
- United Kingdom5.1%
- Australasia0.2%
- Japan0.2%
- Asia Developed0.1%
Share of the stocks in the fund.
Company size
Average market cap 29.8B- Mega cap8.3%
- Big cap21.8%
- Medium cap41.3%
- Small cap22.8%
- Micro cap5.2%
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc fund profile
- Fund name
- Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc
- Ticker
- XGEN.XETRA
- Exchange
- XETRA Stock Exchange
- Index tracked
- Morningstar Gbl Health NR USD
- Category
- Healthcare Equity
- Domicile
- Irland
- Inception date
- Jul 12, 2022
- Trading currency
- EUR
- Expense ratio
- 0.30%